Characterization of cis-acting sequences involved in canine adenovirus packaging

Molecular Therapy : the Journal of the American Society of Gene Therapy
C SoudaisEric J Kremer

Abstract

The cis-acting packaging domain in adenovirus serotype 5 (Ad5) is a series of redundant, albeit not functionally equivalent, "A-repeats" made up of the consensus sequence 5'-TTTGN(8)CG-3'. A-repeats may bind trans-acting factors that direct packaging of the adenovirus genome into the preformed capsid. To try to understand this basic mechanism, we examined the packaging domain from a nonhuman adenovirus. We delimited the canine adenovirus type 2 (CAV-2) packaging domain to within 156 bp via a conditional mutation based on the Cre/loxP excision. Using an insertion, deletion, and substitution strategy, we generated packaging-defective CAV-2 vectors. Our results demonstrate that, like Ad5, CAV-2 cis-acting packaging sequences are located near the left inverted terminal repeat and are redundant, but not functionally equivalent. However, the bipartite motif found in Ad5 is present only once in CAV-2 and deletion of it caused only a minor variation in the packaging efficiency. We have identified at least four functional cis-acting packaging sequences in CAV-2. The CAV-2 vectors that we generated were not replication-defective in an E1-transcomplementing cell line and as heat stable as the parental vectors that did not contain mutations.

References

Aug 1, 1976·Journal of Virology·B EdvardssonL Philipson
Feb 1, 1992·Journal of Virology·M Gräble, P Hearing
Nov 1, 1986·Virus Research·L D Kosturko, M Vanech
Jun 14, 1967·Journal of Molecular Biology·B Hirt
May 1, 1995·The Journal of Infectious Diseases·P FlomenbergJ T Casper
Oct 1, 1994·Current Opinion in Biotechnology·B Sauer
Jan 1, 1995·The Journal of General Virology·S K MittalL A Babiuk
Dec 1, 1994·Virology·A Bailey, V Mautner
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y YangJ M Wilson
Nov 1, 1996·Journal of Virology·N MitterederB C Trapnell
Nov 1, 1996·Human Molecular Genetics·Y YangJ M Wilson
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·R J ParksF L Graham
Dec 31, 1997·Human Gene Therapy·F Paillard
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·M A MorsyC T Caskey
Jul 11, 1998·Journal of Virology·S I Schmid, P Hearing
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·G J Nabel

❮ Previous
Next ❯

Citations

Jul 6, 2012·Gene Therapy·P FernandesP M Alves
Jun 26, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Claire HippertVasiliki Kalatzis
Nov 12, 2005·Journal of Virology·Matthieu Perreau, Eric J Kremer
Sep 17, 2013·PloS One·Estel GilMiguel Chillon
Mar 13, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nicolas SerratriceEric J Kremer
May 2, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Emily N J OrdLorraine M Work
Aug 25, 2015·Current Opinion in Pharmacology·Felix Junyent, Eric J Kremer
Aug 9, 2007·Virus Research·Li Xing, Suresh Kumar Tikoo
Nov 22, 2005·Vaccine·Dinesh S Bangari, Suresh K Mittal
Oct 18, 2005·Brain Research·Bethany N SotakRichard D Palmiter
May 23, 2015·Applied Microbiology and Biotechnology·R CastroA S Coroadinha
Feb 25, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Akseli HemminkiDavid T Curiel
Dec 22, 2005·Biotechnology Letters·Hai-Rong Cheng, Ning Jiang
Jan 21, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kevin R CoffeyJohn F Neumaier
Oct 24, 2003·The Journal of General Virology·Li XingSuresh Kumar Tikoo
Aug 21, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C SoudaisE J Kremer
Dec 23, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Claire SoudaisEric J Kremer
Apr 16, 2019·Frontiers in Molecular Neuroscience·Danila Del RioEric J Kremer
Feb 26, 2019·Frontiers in Molecular Neuroscience·Christelle LasbleizJean-Michel Verdier
Mar 17, 2020·Frontiers in Molecular Neuroscience·Andréanne Lavoie, Bao-Hua Liu
Aug 20, 2021·Scientific Reports·Hiromichi MatsugoTaisuke Horimoto
Aug 22, 2021·Laboratory Investigation; a Journal of Technical Methods and Pathology·Abdul Mohin SajibBruce F Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

© 2021 Meta ULC. All rights reserved